Sarepta Therapeutics saw its shares hit a new multiyear high on Friday after the firm announced that it received a key approval from the FDA.
Chris Lange Amicus Therapeutics is another biotech player seeing a nice boost from the World Muscle Society Conference in France.
Chris Lange Catabasis Pharmaceuticals shares continued their incredible climb after the announcement of positive efficacy results from its MoveDMD trial in a late-breaking session at the World Muscle Society Conference in France.
Chris Lange Sarepta Therapeutics, Inc. (NASDAQ: SRPT) saw its shares make a handy gain on Monday after the firm received an upgrade from Morgan Stanley. The driving force behind this upgrade is Sarepta’s Duchenne…
Chris Lange courtesy of Jon OggStocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one trend that has been proven time after time in this eight-year bull…
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
Sarepta Therapeutics saw its shares make a handy gain on Wednesday after the firm announced muscle biopsy results from its mid-stage study for the treatment of Duchenne muscular dystrophy.
Chris Lange Wednesday’s top analyst upgrades, downgrades and initiations included AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor and Wynn Resorts,
A recent research report from the biotech team at Baird offers their top picks for 2017. While hardly pounding the table, they are cautiously optimistic on the industry.
Considering the new Trump administration, there is an increasingly positive sentiment in the health care sector. In the past year, the health care sector was in trouble under fire from congressional hearings…
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Abercrombie, Nokia, Disney, Xerox, Verizon, Vodafone and Sarepta.
2016 was hard for biotech stocks, some more than others. These three present a buy low opportunity.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include CONSOL Energy, Kroger, 3M, NVIDIA, Qualcomm and Xilinx.
Shares of Summit Therapeutics more than doubled on Tuesday after it was announced that it would be entering into a licensing deal with Sarepta Therapeutics.
Chris Lange Over the past week, a few biotech companies made absolutely massive runs. The companies 24/7 Wall St. has picked stood out from the rest with at least 25% gains.
